Cue Biopharma Welcomes Tamar Howson to its Board of Directors

...CAMBRIDGE, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) --Cue Biopharma, Inc.(NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modul...
Read Full Article